Primo Biotechnology Raises NT$220M in Series A Funding

contact@venturedealtracker.com | Posted on July 2, 2025 |

Here’s the information extracted from the provided text:

Startup Information

Startup Name: Primo Biotechnology
Founders: Dr. Ya-Yao Huang (CEO)
Location: Taipei, Taiwan

Funding Information

Funding Round: Series A
Amount Raised: NT$220M
Total Fundraised to Date: NT$500M
Date of Fundraise: 02/07/2025

Investors

Backers: Not disclosed

Additional Information

Use of Funds: Expand operations and R&D efforts.
Focus Area: Development and manufacturing of radiopharmaceuticals for precision cancer care.
Recent Achievements: Official authorization from ABX advanced biochemical compounds GmbH for manufacturing and distribution of radiopharmaceuticals in Taiwan.

Please let me know if you need more details!

Source link

2025-07-02 14:25:15